Hims & Hers Plunges After Q1 Miss: Is the GLP-1 Pivot Enough to Fuel a Recovery?
Shares of telehealth provider sold off sharply following disappointing Q1 FY2026 financial results, with shares falling more than 12% in after-hours trading after the company reported on May 11. Expectations for the quarter were high, particularly after partnering with Danish multinational pharmaceutical company Novo Nordisk. In March, Novo Nordisk dismissed its patent infringement lawsuit against ...










